Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis

被引:35
作者
Beeston, Tara [1 ]
Smith, Trevor R. F. [1 ]
Maricic, Igor [1 ]
Tang, Xiaolei [1 ]
Kumar, Vipin [1 ]
机构
[1] Torrey Pines Inst Mol Studies, Lab Autoimmun, San Diego, CA 92121 USA
基金
美国国家卫生研究院;
关键词
Regulatory T cells; Fas/FasL; Perforin; EAE; TCR vaccination; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; FAS-LIGAND INTERACTION; MULTIPLE-SCLEROSIS; ANTIGEN; MYELIN; MICE; VACCINATION; INDUCTION; TCR;
D O I
10.1016/j.jneuroim.2010.07.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoaggressive, myelin-reactive T cells are involved in multiple sclerosis and its prototype experimental autoimmune encephalomyelitis (EAE) in mice. A peripheral negative feedback mechanism involving regulatory CD4+ and CD8+T cells (Treg) operates to suppress disease-mediating T cell responses. We have recently characterized a novel population of Qa-1a-restricted, TCR-peptide-reactive CD8 alpha alpha+TCR alpha beta+ Treg that induce apoptotic depletion of the encephalitogenic V beta 8.2 cells in vivo and provide protection from EAE. Here we have used mice deficient in perforin. Fas/FasL and IFN-gamma molecules to investigate their role in Treg-mediated regulation of EAE. Data show that Fas/FasL interactions are not involved, but regulation mediated by Treg is dependent on the presence of IFN-gamma and the perforin pathway. These data provide a molecular mechanism of Treg-mediated killing of the pathogenic T cells and have important implications in the design of immune interventions for demyelinating disease. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 55 条
[21]   CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice [J].
Jiang, H ;
Braunstein, NS ;
Yu, B ;
Winchester, R ;
Chess, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :6301-6306
[22]   FAS(CD95) FASL INTERACTIONS REQUIRED FOR PROGRAMMED CELL-DEATH AFTER T-CELL ACTIVATION [J].
JU, ST ;
PANKA, DJ ;
CUI, HL ;
ETTINGER, R ;
ELKHATIB, M ;
SHERR, DH ;
STANGER, BZ ;
MARSHAKROTHSTEIN, A .
NATURE, 1995, 373 (6513) :444-448
[23]   FAS AND PERFORIN PATHWAYS AS MAJOR MECHANISMS OF T-CELL-MEDIATED CYTOTOXICITY [J].
KAGI, D ;
VIGNAUX, F ;
LEDERMANN, B ;
BURKI, K ;
DEPRAETERE, V ;
NAGATA, S ;
HENGARTNER, H ;
GOLSTEIN, P .
SCIENCE, 1994, 265 (5171) :528-530
[24]   Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis [J].
Karandikar, NJ ;
Crawford, MP ;
Yan, X ;
Ratts, RB ;
Brenchley, JM ;
Ambrozak, DR ;
Lovett-Racke, AE ;
Frohman, EM ;
Stastny, P ;
Douek, DC ;
Koup, DA ;
Racke, MK .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (05) :641-649
[25]   LESS MORTALITY BUT MORE RELAPSES IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN CD8-/- MICE [J].
KOH, DR ;
FUNGLEUNG, WP ;
HO, A ;
GRAY, D ;
ACHAORBEA, H ;
MAK, TW .
SCIENCE, 1992, 256 (5060) :1210-1213
[26]   THE T-CELL RECEPTOR REPERTOIRE AND AUTOIMMUNE-DISEASES [J].
KUMAR, V ;
KONO, DH ;
URBAN, JL ;
HOOD, L .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :657-682
[27]   Homeostatic control of immunity by TCR peptide-specific Tregs [J].
Kumar, V .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) :1222-1226
[28]  
Kumar V, 1998, J IMMUNOL, V161, P6585
[29]   THE INVOLVEMENT OF T-CELL RECEPTOR PEPTIDE-SPECIFIC REGULATORY CD4+ T-CELLS IN RECOVERY FROM ANTIGEN-INDUCED AUTOIMMUNE-DISEASE [J].
KUMAR, V ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :909-916
[30]   Induction of a type 1 regulatory CD4 T cell response following Vβ8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis [J].
Kumar, V ;
Maglione, J ;
Thatte, J ;
Pederson, B ;
Sercarz, E ;
Ward, ES .
INTERNATIONAL IMMUNOLOGY, 2001, 13 (06) :835-841